Elevation of Intact Parathyroid Hormone Level Is a Risk Factor for Low Bone Mineral Density in Pretransplant Patients With Liver Diseases
Authors:
- 1 December 2007
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (10) , 3182-3185
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pathogenesis of osteoporosis: concepts, conflicts, and prospectsJournal of Clinical Investigation, 2005
- VITAMIN D IN HEALTH AND DISEASE: Role of Parathyroid Hormone and Therapy with Active Vitamin D Sterols in Renal OsteodystrophySeminars in Dialysis, 2005
- Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?Current Opinion in Nephrology and Hypertension, 2005
- Bone mineral density among cirrhotic patients awaiting liver transplantationLiver Transplantation, 2004
- Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problemLiver Transplantation, 2003
- The heterogeneity of bone disease in cirrhosis: a multivariate analysisOsteoporosis International, 2003
- Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometryHepatology, 2002
- Bone disease after liver transplantationLiver Transplantation, 2001
- Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up studyThe Lancet, 2001
- Hepatic OsteodystrophyHepatology, 2001